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Heinz et al. identify the lipid-modulating
phosphodiesterase SMPDL3B as
negative regulator of Toll-like receptor
function. Smpdl3b-deficiency strongly
affected macrophage lipid composition
and fluidity and led to higher
responsiveness to TLR stimulation.
Peritonitis models in Smpdl3b-deficient
mice confirmed the negative regulatory
role in vivo.
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Lipid metabolism and receptor-mediated signaling
are highly intertwined processes that cooperate to
fulfill cellular functions and safeguard cellular ho-
meostasis. Activation of Toll-like receptors (TLRs)
leads to a complex cellular response, orchestrating
a diverse range of inflammatory events that need
to be tightly controlled. Here, we identified the
GPI-anchored Sphingomyelin Phosphodiesterase,
Acid-Like 3B (SMPDL3B) in a mass spectrometry
screening campaign for membrane proteins co-pur-
ifying with TLRs. Deficiency of Smpdl3b in macro-
phages enhanced responsiveness to TLR stimulation
and profoundly changed the cellular lipid composi-
tion and membrane fluidity. Increased cellular re-
sponses could be reverted by re-introducing affected
ceramides, functionally linking membrane lipid
composition and innate immune signaling. Finally,
Smpdl3b-deficient mice displayed an intensified in-
flammatory response in TLR-dependent peritonitis
models, establishing its negative regulatory role
in vivo. Taken together, our results identify the mem-
brane-modulating enzyme SMPDL3B as a negative
regulator of TLR signaling that functions at the inter-
face of membrane biology and innate immunity.
INTRODUCTION
Toll-like receptors (TLRs) are important sensors of pathogens as
well as cellular and environmental stress (Kawai and Akira, 2010;CeMoresco et al., 2011; O’Neill, 2008). Stimulation of these recep-
tors leads to a complex inflammatory response, orchestrating a
diverse range of cellular functions such as cytokine secretion,
cell migration, and antigen presentation (Kawai and Akira,
2007). To avoid unnecessary tissue damage or manifestation
of chronic inflammation, these events are tightly controlled (Ka-
wai and Akira, 2010; Liew et al., 2005; Medzhitov, 2008). Many
proteins have been identified previously as regulators of TLRs
acting via different mechanisms (Kondo et al., 2012; Lee et al.,
2012; Liew et al., 2005). These include accessory proteins
involved in folding and vesicular transport, facilitators of recep-
tor-ligand interactions, transcriptional regulators as well as intra-
cellular proteins involved in activation of receptor-proximal
signaling.
Lipids are involved in most cellular processes by serving at the
same time as structural components of membranes, energy
storage molecules, and second messengers in signaling events
(Hannun and Obeid, 2008; vanMeer et al., 2008). While the func-
tion of membrane-bound or associated proteins is strongly influ-
enced by the lipid composition and state of the accommodating
membrane, the molecular connections responsible for these re-
lationships are only beginning to be elucidated (Ernst et al.,
2010). Stimulation of macrophages with TLR ligands strongly im-
pacts on cellular gene expression and morphology. This also
involves regulation of the cellular lipid repertoire, further high-
lighting the high degree of interdependence of these processes
(Andreyev et al., 2010; Dennis et al., 2010;Maurya et al., 2013). In
addition to the TLRs themselves, several components of the re-
ceptor sorting and signaling machinery are associated with
different cellular membranes (Gay et al., 2014). This extensive
interconnection withmembrane biology suggests that the recep-
tor function is sensitive to changes in cellular lipid composition.
Therefore, it is not surprising that perturbations influencingll Reports 11, 1919–1928, June 30, 2015 ª2015 The Authors 1919
cellular lipid flux or membrane microdomain composition
have been shown to affect TLR-dependent signaling events
(Fessler and Parks, 2011; Triantafilou et al., 2002, 2004; Zhu
et al., 2010).
Here, we report on the identification of SMPDL3B as a lipid-
modifying enzyme and demonstrate its involvement in the regu-
lation of TLR-induced signaling processes. We could show that
this GPI-anchored glycoprotein is prominently expressed on
macrophages and dendritic cells (DCs) and further strongly
upregulated by TLR stimuli and interferon gamma (IFN-g). Func-
tionally, Smpdl3b-deficient macrophages and DCs showed
hyper-responsiveness to TLR stimulation, suggesting a negative
regulatory role for SMPDL3B in TLR-induced signaling. Enzy-
matic measurements revealed that SMPDL3B is a potent phos-
phodiesterase active on the surface of these cells. Identifying a
role in lipid metabolism, Smpdl3b knockdown or knockout mac-
rophages showed a strong reduction in membrane order. This
was further highlighted by changes associated with SMPDL3B
depletion on the global cellular lipid composition as assessed
by lipidomics analysis. In particular, specific ceramide species
appeared to be depleted. Supplementation of these lipids in
Smpdl3b knockdown cells reverted their hyper-inflammatory
phenotype, thus confirming an implication of these molecules
in the regulation of TLR signaling. Finally, Smpdl3b-deficient
mice manifested higher inflammatory responses in models of
TLR-dependent peritonitis, establishing the importance of this
enzyme in vivo. Taken together, our results identify SMPDL3B
as lipid-modifying enzyme that acts as a negative regulator of
TLR signaling at the interface of lipid metabolism and inflamma-
tory signaling.
RESULTS
Identification of SMPDL3B as GPI-Anchored TLR
Interactor
The discovery of proteins modulating the activity of TLRs is
crucial for the understanding of TLR-dependent immune re-
sponses. The characterization of TLR-associated protein com-
plexes by affinity purification followed by mass spectrometry
has previously led to the identification of CD14 as co-receptor
for nucleic acid recognition by the endosomal TLRs 7 and 9
(Baumann et al., 2010). In the same screening campaign,
SMPDL3B (UniProt: P58242, entry name: ASM3B_MOUSE)
was consistently identified as membrane protein co-purifying
with endosomal TLRs 3, 7, 8, and 9 with robust sequence
coverage from RAW264.7 macrophages suggesting association
with the same membrane compartments harboring TLRs
(Figure 1A).
SMPDL3B contains an N-terminal signal peptide (amino acid
[aa] 1–18), a central metallo-phosphodiesterase domain
(MPP_ASMase, aa 23–323) as well as a C-terminal GPI-mem-
brane anchor signal and belongs to a small family of three
evolutionarily related enzymes (Figure 1B) (Masuishi et al.,
2013). Of these, Sphingomyelin Phosphodiesterase 1/Acid
Sphingomyelinase (SMPD1/ASM) is a well-characterized lyso-
somal protein involved in the degradation of sphingomyelin to
ceramide and phosphorylcholine (Hannun and Obeid, 2011;
Milhas et al., 2010; Seto et al., 2004). In contrast, less is known1920 Cell Reports 11, 1919–1928, June 30, 2015 ª2015 The Authorsabout the precise functions of the related proteins SMPDL3A
and SMPDL3B. SMPDL3A was shown to be regulated by the
oxysterol-inducible transcription factor LXRa, linking it to lipid
metabolism, and recently confirmed to harbor phosphodies-
terase activity (Noto et al., 2012; Pehkonen et al., 2012; Traini
et al., 2014). SMPDL3B was shown to be a membrane-associ-
ated protein proposed to play a role in podocytes in human kid-
ney diseases including focal segmental glomerulosclerosis as
well as diabetic kidney disease (Fornoni et al., 2011; Yoo
et al., 2015).
To study the topology of SMPDL3B and related proteins in
overexpression experiments, HEK293T cells were transiently
transfected or stably transduced with the corresponding expres-
sion constructs (Figure S1A). SMPDL3B could be detected on
the surface of HEK293T cells stably expressing the protein while
mutants lacking the C-terminal GPI-membrane anchor signal
(SMPDL3BDGPI) accumulated in cell supernatants (Figures
1C, S1A, and S1B). While overexpressed SMPDL3A was also
detected in cell supernatants, confirming a previous report that
it is a secreted protein (Traini et al., 2014), SMPD1/ASM, a
well-established lysosomal protein, was not found at this loca-
tion (Figure S1B). Confocal microscopy of overexpressed
SMPDL3B in HEK293T cells confirmed the predominantly sur-
face-associated localization (Figure S1C). As the co-purification
of SMPDL3B with several TLRs was initially observed in
RAW264.7 macrophages, we used these cells to study the prop-
erties of the endogenous protein. In line with the human variant
(Masuishi et al., 2013), endogenous murine SMPDL3B was en-
riched in themembrane fraction of these cells and showed sensi-
tivity to phosphatidylinositol-specific phospholipase C (PI-PLC)
treatment, an enzyme known to cleave GPI anchors (Figures
1D, 1E, and S1D). Additionally, we assessed the presence of
N-linked glycosylation sites on murine or human SMPDL3B or
murine SMPDL3A and found that all proteins were highly glyco-
sylated as evidenced by sensitivity of proteins to PNGase F
(Figure S1E).
GPI-anchored proteins such as the TLR co-receptor CD14 are
known to localize to sphingomyelin- and cholesterol-enriched
membrane subdomains that can be purified based on their insol-
ubility in certain detergents (Mayor and Riezman, 2004). We
found SMPDL3B and CD14 both enriched in these detergent
resistant membranes isolated from RAW264.7 macrophages
(Figure S1F). In this light, we also evaluated whether the associ-
ation of SMPDL3Bwith TLRs could be confirmed by co-immuno-
precipitation (Figure 1F). SMPDL3B co-purified with the TLRs 4,
7, 8, and 9 and only weakly with TLR3 (Figure 1F), thus indeed
resembling the behavior of CD14 (Baumann et al., 2010; Lee
et al., 2012). Although these data are compatible with physical
proximity of SMPDL3B and TLRs, it is also possible that the
observations made reflect the presence of these proteins in
membrane and/or detergent complexes obtained under the
experimental solubilization conditions used, without the involve-
ment of direct protein-protein interactions.
Taken together, we found that SMPDL3B is a GPI-anchored
glycoprotein with putative enzymatic function that efficiently
co-purified with several TLRs frommacrophages and was there-
fore chosen for further functional evaluation as potential modu-




Figure 1. Identification of SMPDL3B as GPI-Anchored TLR Interactor
(A) Average spectral counts (av spc) and average% sequence coverage (av%sc) of SMPDL3B detected bymass spectrometry in endosomal TLR tandem affinity
purifications.
(B) Domain organization of SMPDL3B, SMPDL3A, and SMPD1/ASM. Gray triangles indicate predicted or validated N-linked glycosylation sites; black triangles
indicate conserved motifs in metal coordination/substrate binding.
(C) HA-specific FACS analysis of HEK293T cells stably expressing murine SMPDL3B or a deletion mutant lacking the C-terminal GPI signal.
(D) Cells were lysed using 1% NP-40 or subjected to TX-114 phase separation. Proteins were analyzed by western blot for SMPDL3B, CD14, and IkBa. I,
detergent-insoluble proteins; D, detergent phase, amphiphilic integral membrane proteins; A, aqueous phase, hydrophilic proteins.
(E) Cells were lysed with TX-114; lysates were divided in two and treated or not with PI-PLC. Proteins were subjected to phase separation, and fractions were
analyzed by western blot for SMPDL3B, CD14, and IkBa.
(F) HEK293T cells were transfected with SMPDL3B and V5-tagged TLRs as indicated. Immunoprecipitates and extracts were analyzed by western blot using
SMPDL3B- and V5-specific antibodies.
(C–F) Data are representative of at least two independent experiments. See also Figure S1.SMPDL3B Is a Negative Regulator of TLR Signaling
SMPDL3B expression was prominently observed in macro-
phages and DCs (Figure S1G). Consistent with a possible role
for this enzyme in the course of inflammatory processes,
Smpdl3b transcription in bone marrow-derived macrophages
(BMDMs) and DCs (BMDCs) was robustly induced upon TLR
stimulation (Figure 2A). To further study the role of this protein
in primary cells, we decided to generate Smpdl3b-deficient
mice. The knockout mice were viable and did not have any overt
developmental phenotype. Interestingly, BMDMs and BMDCs
from Smpdl3b-deficient mice showed higher expression and
release of the chemokine KC/CXCL1 upon stimulation with
TLR agonists in comparison to wild-type cells (Figures 2B–2F
and S2A). In line with this, knockdown of Smpdl3b in
RAW264.7 macrophages increased the release of interleukin 6
(IL-6) upon treatment with lipopolysaccharide (LPS), CpG-DNA
(CpG), and imiquimod (IMQ) (Figures S2B and S2C). To evaluate
whether other important membrane-dependent events thatCeoccur early upon TLR activation were affected by SMPDL3B
depletion, we measured the internalization rates of TLR4 and
the phagocytic uptake of CpG (Figures S2D–S2F). Endocytosis
of TLR4 upon LPS stimulation was unchanged in RAW264.7
macrophages or primary BMDMs depleted or deficient in
Smpdl3b, suggesting that the enhanced release of cytokines in
SMPDL3B-depleted cells was not caused by retaining TLR4 at
the plasmamembrane ormalfunctioning of receptor endocytosis
(Figures S2D and S2E). Also, uptake of fluorescently labeled
Cy3-CpG was unaltered in knockdown cells further indicating
that endocytic functions were intact (Figure S2F). Taken
together, these data show that Smpdl3b expression is induced
upon TLR stimulation and reveal that SMPDL3B negatively af-
fects TLR-dependent responses.
SMPDL3B Affects TLR-Dependent Signaling Processes
TLR signaling proceeds through the activation of mitogen-acti-





Figure 2. SMPDL3B Is a Negative Regulator of
TLR Signaling
(A) BMDMs or BMDCs were stimulated with 100 ng/ml
LPS or 1 mM CpG-DNA for the indicated time and
relative expression of Smpdl3b was measured by RT-
PCR.
(B) Expression of SMPDL3B and tubulin in wild-type
and Smpdl3b-deficient BMDMs was analyzed by
western blot.
(C and E) BMDMs or BMDCs from wild-type (WT) or
Smpdl3b-deficient (KO) mice were stimulated with
100 ng/ml LPS for the indicated time, and relative
expression of KC was measured by RT-PCR.
(D and F) BMDMs or BMDCs from wild-type (WT) or
Smpdl3b-deficient (KO) mice were stimulated with
LPS for 8 hr, and supernatants were analyzed for KC by
ELISA.
(G) The phosphorylation status of p38, JNK, and ERK
and protein levels of IkBa in the lysates of control
(shCTRL) and SMPDL3B-depleted RAW264.7 cells
(shS3B) upon stimulation with LPS were analyzed by
western blot.
(A and C–F) Data show mean ± SD of technical tripli-
cates and are representative of at least two indepen-
dent experiments. (G) Data are representative of two
independent experiments. See also Figure S2.NF-kB (Arthur and Ley, 2013; Kawai and Akira, 2007). To deter-
mine the effect of Smpdl3b knockdown on these signaling
events, we monitored phosphorylation of the MAPKs p38a,
c-Jun N-terminal kinase (JNK) or extracellular signal-regulated
kinase (ERK) (Figure 2G). SMPDL3B-depleted cells showed
higher levels of phosphorylated p38a and JNK, whereas phos-
phorylation of ERK appeared rather reduced. In addition to
the differences in these important phosphorylation events,
SMPDL3B-depleted macrophages showed sustained degrada-1922 Cell Reports 11, 1919–1928, June 30, 2015 ª2015 The Authorstion of IkBa, which is indicative of enhanced
NF-kB activity (Figure 2G). Together, these
results revealed that signaling processes
occurring relatively early after TLR engage-
ment are affected by the absence of
SMPDL3B.
Identification of SMPDL3B as TLR-
Inducible Neutral Phosphodiesterase
The similarity to other phosphodiesterases
prompted us to assess SMPDL3B activity
by monitoring phosphodiesterase-depen-
dent hydrolysis of chromogenic bis(4-nitro-
phenyl)phosphate (bis-pNPP) (Figure S3A).
Recombinant SMPDL3B lacking the C-termi-
nal GPI signal, purified from supernatants of
Sf9 insect cells or HEK293T cells, efficiently
hydrolyzed the substrate, exerting highest
activity at neutral pH (Figures 3A, 3B, and
S3B). This indicated that the enzyme is fully
active at the pH found at the plasma mem-
brane location. Confirming specificity, a
mutant (H135A) replacing a conserved histi-dine residue of SMPDL3B predicted to be involved in substrate
hydrolysis (Seto et al., 2004), showed reduced enzymatic activity
(Figure 3C). In line with the abundant expression on the plasma
membrane, substrate hydrolysis could also be detected on
HEK293T cells stably expressing murine or human SMPDL3B,
indicating that this assay was well suited for measuring activity
on the surface of intact cells (Figures 3D, S3C, and S3D). Indeed,
RAW264.7 cells showed robustly detectable enzymatic activity,
which was strongly reduced in the Smpdl3b knockdown cells,
A B C
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Figure 3. Enzymatic Activity and Inducibility
of SMPDL3B
(A) Substrate velocity curve and Lineweaver-Burk
diagram for murine SMPDL3B produced in Sf9 in-
sect cells.
(B) Influence of pH on the enzymatic activity of
murine SMPDL3B produced in Sf9 insect cells.
(C) Coomassie staining of SDS-PAGE gel contain-
ing equal amounts of human or mouse SMPDL3B
and H135A point mutants. Bar graphs show phos-
phodiesterase activity of the indicated proteins.
(D) Measurement of phosphodiesterase activity on
HEK293T cells stably expressing an empty vector
(mock) or murine SMPDL3B.
(E) Phosphodiesterase activity on control (shCTRL)
and Smpdl3b-depleted (shSMPDL3B) RAW264.7
cells.
(F) Wild-type (wt) or Smpdl3b-deficient (ko) BMDMs
were stimulated or not with 100 ng/ml LPS, 1 mM
CpG, 2.5 mM IMQ, 200 ng/ml Pam3Csk4 (P3C4),
and 1,000 U/ml IFN-b or 1,000 U/ml IFN-g for 16 hr,
and SMPDL3B or Actin protein levels were analyzed
by western blotting. Bar graphs represent phos-
phodiesterase activity measured after stimulation.
(A and C) Data are representative of at least two
independent experiments. (B and D–F) Data show
mean ± SD of technical triplicates and are repre-
sentative of at least two independent experiments.
See also Figure S3.highlighting SMPDL3B as an important phosphodiesterase
enzyme significantly contributing to substrate hydrolysis on
macrophages (Figures 3E and S3E).
Given that Smpdl3b transcription was upregulated upon TLR
activation in macrophages and DCs (Figure 2A), we next deter-
mined the effect of inflammatory stimuli on protein levels and
enzymatic activity. In line with enhanced transcription,
SMPDL3B protein levels were upregulated in BMDMs upon
stimulation with different TLR ligands, including LPS, CpG,
IMQ, and Pam3CSK4, and also the pro-inflammatory cytokine
interferon g (Figure 3F). Consistent results were also obtained
for RAW264.7 macrophages (Figure S3F). The cellular enzymatic
activity correlated well with the protein levels and was strongly
reduced in BMDMs from knockout mice, further highlighting
SMPDL3B as the dominant phosphodiesterase on the surface
of these immune cells (Figure 3F).
Deficiency in SMPDL3B Leads to a Global Increase
in Membrane Fluidity
To evaluate the impact of SMPDL3B, a lipid-associated enzyme,
on the cellular membrane environment, wemeasuredmembrane
fluidity of macrophages. The lipid phase of membranes in intact
cells can be studied using fluorescent probes that alter their
spectral emission properties dependent on lipid packing and
can thus reflect membrane order (Owen et al., 2012). The gener-
alized polarization (GP) function can be used to calculate a
normalized ratio between the measured intensities of ordered
and unordered fractions in fluorescence microscopy images
and therefore allows the quantification of changes in membrane
order. In line with a role for SMPDL3B in membrane biology, mi-
croscopy-based measurements of membrane fluidity using theCefluorescent probe di-4-ANEPPDHQ revealed a strong decrease
of membrane order (i.e., increase of membrane fluidity) in
SMPDL3B-depleted RAW264.7 macrophages (Figures 4A–4C).
Treatment with the cholesterol-extracting agent methyl-b-cyclo-
dextrin (MbCD) also led to reduced measureable membrane
order and served as a positive control for this assay system.
As an increase in membrane fluidity associated with SMPDL3B
knockdown might affect the integrity of lipid rafts found on the
cell surface, we measured the concentration of the raft marker
GM1 ganglioside by flow cytometry. Interestingly, the concentra-
tion of GM1 was not affected by knockdown of Smpdl3b, sug-
gesting no general modulatory effect on lipid raft abundance
(Figure S4A). Highly consistent with the data obtained in
RAW264.7 cells, also Smpdl3b-deficient BMDMs showed a
decrease in membrane order, indeed assigning a role to
SMPDL3B in membrane biology (Figure 4D).
Lipidomics Analysis
The clear changes of membrane fluidity in SMPDL3B knock-
down or knockout cells strongly suggested that the TLR-modu-
lating activity of SMPDL3B is associated with a change inmacro-
phage lipid composition. To test this, we assessed the global
impact of SMPDL3B on the cellular lipid repertoire by mass
spectrometry-based lipidomics. RAW264.7 cells were incubated
for 2 hr in serum-free medium and lipids from control (shCTRL)
and SMPDL3B-depleted cells (shSMPDL3B) were extracted
and analyzed for sphingo- and glycerophospholipid as well as
cholesterol levels (Table S1). In line with the strong reduction in
membrane order, knockdown of SMPDL3B led to a profound
global change in the cellular lipid composition, with significant al-




Figure 4. SMPDL3B Alters the Biophysical
Properties and Composition of Cellular
Membranes
(A–D) Membrane fluidity measurements. (A)
Confocal images pseudocolored based on GP
values (see color bar). Left: shCTRL; right:
shSMPDL3B. Scale bar, 20 mm. (B) GP value dis-
tribution from representative experiment. Mean ±
SEM, n = 7. (C) Fraction of ordered membrane of
RAW264.7 relative to shCTRL. Mean ± SD of at
least three biological replicates is shown. (D)
Fraction of ordered membrane of BMDMs relative
to WT. Mean ± SD, n = 5. Figure is representative
of two biological replicates.
(E) Lipids were extracted from control (shCTLR) or
SMPDL3B-depleted (shSMPDL3B) RAW264.7
macrophages and analyzed by MS for glycer-
ophospho- and sphingolipids. Bubble plots
represent mean log2-transformed fold-change
differences between cell lines. SM, sphingomyelin;
GluCer, glucosylceramide; Cer, ceramide; PC,
(lyso-) phosphatidylcholine; PE, (lyso-) phosphati-
dylethanolamine; PA, phosphatidic acid; PI, (lyso-)
phosphatidylinositol; PS, (lyso-) phosphatidylser-
ine; PG, phosphatidylglycerol. Data are represen-
tative of two biological replicates each consisting
of five technical replicates.
(F) Relative lipid levels for ceramide in control
(shCTRL) and SMPDL3B-depleted RAW264.7
macrophages (shSMPDL3B). Cer d18:1/16:0 is
abbreviated as C16:0, Cer d18:1/22:0 as C22:0,
Cer d18:1/24:0 as C24:0, and Cer d18:1/24:1 as
C24:1. Data represent mean ± SEM of two bio-
logical replicates each consisting of five technical
replicates. *p% 0.05.
(G) Control (shCTRL) and SMPDL3B-depleted
RAW264.7 macrophages (shSMPDL3B) were
pretreated for 30 min with vehicle (VEH) or the indicated synthetic ceramide species (15 mM) and then stimulated with 100 ng/ml LPS for 8 hr. IL-6 release was
measured by ELISA.
Data show mean ± SD of technical triplicates and is representative of at least two independent experiments. See Figure S4.classes (Figures 4E, S4B, and S4C). Among sphingolipid spe-
cies, significant decreases were observed for ceramide species
upon knockdown of SMPDL3B, and two sphingomyelin species
were significantly increased while five were decreased (Figures
4E and S4B). Also, glycerophospholipids were strongly affected
by SMPDL3B depletion. Phosphatidylcholine species were
rather increased, whereas most phosphatidylethanolamine,
-inositol and -serine, were decreased (Figures 4E and S4B).
Finally, cellular cholesterol levels were also significantly
decreased in SMPDL3B-depleted cells (Figure S4D). Taken
together, our membrane fluidity and lipidomics measurements
identified SMPDL3B as regulator of macrophage membrane
composition and order.
Silencing of Smpdl3b Leads to a Pro-inflammatory Lipid
State
Given that the depletion of SMPDL3B in RAW264.7 cells did not
only affect a subset of measured lipid species, but led to a
global change in the cellular lipid repertoire, the interpretation
of these data required further analysis. Based on a systematic
perturbation screen targeting genes involved in sphingolipid
metabolism combined with lipidomics analysis and measure-1924 Cell Reports 11, 1919–1928, June 30, 2015 ª2015 The Authorsment of TLR-related processes the function of 245 diverse lipid
species could be inferred (see Ko¨berlin et al., 2015). Utilizing
this resource, we compared the changes in lipid abundance
upon SMPDL3B knockdown with their predicted function in
IL-6 release for those lipid species that were detected in both
lipidomics data sets. Consistent with the increased inflamma-
tory response observed in SMPDL3B-depleted cells, we found
lipids associated with increased IL-6 release upon LPS or CpG
stimulation to be increased in abundance while lipids associ-
ated with reduced IL-6 release were decreased in abundance
(Figure S4E). Interestingly, several ceramide species predicted
to dampen TLR-dependent IL-6 release (Cer d18:1/16:0,
d18:1/22:0, and d18:1/24:1) were significantly reduced upon
SMPDL3B knockdown (Figures 4F and S4E). To validate their
potential involvement in regulating LPS-induced IL-6 release,
we performed lipid supplementation experiments. Indeed,
when control and SMPDL3B-depleted macrophages were
pre-treated with the synthetic ceramide species Cer d18:1/
16:0, Cer d18:1/22:0, and Cer d18:1/C24:0, the SMPDL3B-
dependent increase in IL-6 release upon TLR stimulation could
be reverted (Figures 4G and S4F). Similarly, the IL-6 release
induced upon stimulation with CpG and IMQ was reduced by
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C
Figure 5. SMPDL3B Is a Negative Regulator
of Inflammation In Vivo
(A and B) Wild-type (WT) and Smpdl3b-deficient
(KO) mice were injected with 50 mg LPS i.p. After
6 hr, mice were sacrificed, and (A) peritoneal lavage
was taken and total cells and neutrophils were
counted, and (B) serum IL-6 and TNF were
measured by ELISA.
(C) Wild-type (WT) and Smpdl3b-deficient (KO)
mice were injected i.p. with 1 3 104 cfu of E. coli.
After 6 hr, mice were sacrificed, and the serum
cytokine levels of IL-6, TNF, IL-12p40, KC, IL-10,
and IL-1bwere analyzed by ELISA. Bars are means
of each group ± SEM (*p % 0.05) and are repre-
sentative of two independent experiments, each
performed with eight mice/group.supplementation of ceramide Cer d18:1/24:0 further experi-
mentally confirming the predicted roles on other TLRs
(Figure S4G).
Taken together, changes in cellular lipid species abundance
associated with SMPDL3B depletion were highly indicative of
pro-inflammatory responses. Furthermore, our lipidomics anal-
ysis combined with lipid supplementation experiments allowed
us to highlight several long-chained ceramide species as puta-
tive modulators of the enhanced inflammatory response upon
SMPDL3B depletion.
SMPDL3B Negatively Regulates TLR Activity In Vivo
If, as all evidence so far would show, SMPDL3B is involved in
homeostasis of membrane lipid composition and TLR signaling,
then it should have a role in TLR-mediated inflammatory pro-
cesses in vivo. To assess this, we used an LPS-dependent
mouse inflammation model. Wild-type or Smpdl3b-deficient
mice were injected intraperitoneally with LPS and peritoneal
cell influx as well as serum cytokine levels were determined
6 hr later (Figures 5A and 5B). Smpdl3b-deficient mice con-
tained higher numbers of immune cells in the peritoneal lavage
fluid (PLF), due to a significantly enhanced influx of neutrophils,
in line with an aberrantly strong inflammatory response (Fig-
ure 5A). Concomitantly, Smpdl3b-deficient mice showed
increased IL-6 levels in the serum as compared to control
mice (Figure 5B). Serum levels of TNF were not significantly
affected under these conditions (Figure 5B). To test whether
SMPDL3B also affects the host-response against viable patho-
gens, we used an E. coli-induced peritonitis model. Hence,
wild-type and Smpdl3b-deficient mice were injected with bac-
teria in the peritoneum and serum cytokine levels were quanti-
fied 6 hr later. Serum levels of IL-6, TNF, IL-12p40, and KCCell Reports 11, 1919–192were significantly elevated in Smpdl3b-
deficient mice as compared to wild-type
(Figure 5C). Interestingly, we did not
detect significant alterations in the serum
levels of the cytokines IL-10 and IL-1b,
indicating that not all inflammatory medi-
ators were equally affected by Smpdl3b
deficiency (Figure 5C). Taken together,our experiments indeed establish SMPDL3B as negative regu-
lator of TLR-dependent inflammatory responses in vivo.
DISCUSSION
In the present study, we have identified the GPI-anchored lipid-
modifying enzyme SMPDL3B as negative regulator of TLR
signaling. We found that this sphingomyelinase-related protein
is abundantly expressed on macrophages and DCs and can be
further upregulated by inflammatory stimuli. Furthermore, enzy-
matic assays on intact cells revealed that SMPDL3B is respon-
sible for a large fraction of measurable phosphodiesterase activ-
ity on these important immune cells. Loss-of-function of this
enzyme led to increased cellular responses upon TLR stimula-
tion while Smpdl3b-deficient mice showed enhanced inflamma-
tion in models of TLR-dependent peritonitis. Confirming the
involvement of this protein in lipid metabolism, we found that
lack of the cellular activity of this enzyme was associated with
a significant change in membrane fluidity and the global cellular
lipid composition. Supplementation of specific ceramide
species that were reduced in SMPDL3B-depleted cells was
able to revert the SMPDL3B-dependent hyper-inflammatory
phenotype.
Bioactive lipids such as ceramides, sphingosine-1-phosphate
and phosphatidylinositol derivatives as well as changes in struc-
tural components of cellular membranes have all been impli-
cated in modulation of TLR signaling (Fessler and Parks,
2011; Liew et al., 2005). The inducibility upon TLR stimulation
and impact of SMPDL3B on cellular lipid composition and
consequently membrane fluidity is suggestive of a not yet
described regulatory mode of macrophage function acting at
the interface of membrane biology and inflammatory signaling.8, June 30, 2015 ª2015 The Authors 1925
The lipid environment of TLRs, including membrane microdo-
mains rich in sphingolipids and cholesterol, has been shown
to play a role in receptor function (Fessler and Parks, 2011;
Lingwood and Simons, 2010; Triantafilou et al., 2002, 2004;
Zhu et al., 2010). Perturbations affecting the receptor-accom-
modating membranes, as observed in macrophages defective
for the cholesterol efflux transporters ABCA1 and ABCG1 that
display an increase in free cholesterol, lead to enhanced
responsiveness of TLRs, presumably as a consequence of
altered plasma membrane composition (Draper et al., 2010;
Yvan-Charvet et al., 2008; Zhu et al., 2008, 2010). In cells defi-
cient for SMPDL3B, we could not detect changes in the amount
of GM1, a marker for sphingolipid- and cholesterol-enriched mi-
crodomains, indicating that these structures are intact. Instead,
we observed a global decrease in membrane order and change
in the cellular lipid repertoire that was associated with upregula-
tion of TLR-triggered signaling, suggesting that SMPDL3B ac-
tivity may affect innate immunity signaling by an alternative,
possibly composite mechanism.
Interestingly, whereas TLR receptor-proximal signaling and
cytokine production were clearly changed by SMPDL3B deple-
tion, other processes, including TLR4 surface expression and
endocytosis or CpG uptake, appeared normal. This indicates
that membrane-dependent functions are differently sensitive to
SMPDL3B depletion, which might also affect other TLR-associ-
ated processes including receptor-lipid interactions, adaptor
recruitment dynamics, receptor diffusion and trafficking, or
ligand dissociation (Ernst et al., 2010; Gay et al., 2014). While
in the context of TLR signaling SMPDL3B-depleted or deficient
macrophages manifested a stronger inflammatory response,
the global changes in the cellular lipid repertoire are likely to
have more pleiotropic functional effects and affect other cellular
signaling pathways and processes that were not covered in our
study. Therefore, future experiments will aim at the identification
and elucidation of additional roles of SMPDL3B in macrophages
and other cellular systems in which SMPDL3B is expressed.
Generation of ceramide has been observed in response to
various stimuli, leading to the formation of ceramide-rich mem-
brane platforms, thought to be involved in the regulation of trans-
membrane signaling processes (Hannun and Obeid, 2008; Mil-
has et al., 2010; Stancevic and Kolesnick, 2010). Based on
observations in experimental lipid bilayers, an increase in cer-
amide species causes higher membrane order, highlighting a
regulatory effect of these lipids on membrane biophysical prop-
erties (Stancevic and Kolesnick, 2010). Interestingly, several cer-
amide species (Cer d18:1/16:0, Cer d18:1/22:0, and Cer d18:1/
24:1), which were found to be negatively correlated with TLR-
induced IL-6 release, were also significantly reduced upon
SMPDL3B depletion, potentially explaining the effect on mem-
brane order observed in these cells.
Despite the complexity of the mechanism at play, the specific
and high expression of SMPDL3B in immune cells, the induc-
ibility of its expression and activity by immune stimuli, combined
with the unequivocal phenotype observed in Smpdl3b-deficient
mice, demonstrate an intimate link between a major cell surface
lipid-modulating enzyme and the regulation of pro-inflammatory
processes. Undoubtedly, more connections between meta-
bolism, tissue homeostasis, and the resolution of inflammation1926 Cell Reports 11, 1919–1928, June 30, 2015 ª2015 The Authorsare likely to emerge in the future and further elucidate these inter-
dependent regulatory networks.
EXPERIMENTAL PROCEDURES
Information on reagents, plasmids, cell culture, and protein purification can be
found in the Supplemental Experimental Procedures.
FACS
All samples were analyzed on a BD Biosciences FACSCalibur or LSR Fortessa
flow cytometer. See the Supplemental Experimental Procedures for further
information.
RT-PCR
RNA was isolated with the QIAGEN RNeasy Mini Kit. 100 ng RNA/sample was
reversely transcribed using RevertAid reverse transcriptase (Fermentas).
cDNA was diluted 1:20, and relative transcript levels were analyzed using
SYBR green (GeneXPress) using the following primers: Cyclophilin B 50-CAG
CAA GTT CCA TCG TGT CAT CAA GG-30 and 50-GGA AGC GCT CAC CAT
AGA TGC TC-30; Smpdl3b 50-AAG TCT ATG CTG CTC TGG GAA-30and 50-
TGC CAC CTG GTT ATA GAT GC-30; mKC 50CAATGAGCTGCGCTG
TCAGTG-30 and 50-CTTGGGGACACCTTTTAGCATC-30. Real-time PCR anal-
ysis was performed on a Rotor Gene 6000 (QIAGEN) in technical duplicates or
triplicates. Expression of target genes was normalized to that of the house-
keeping gene Cyclophilin B.
ELISA
All ELISA experiments were performed according to the manufacturers’ in-
structions. The kit for detection of KC was from R&D Systems, TNF was
from BioLegend, and all others were from BD Biosciences.
Triton X-114 Phase Separation and PI-PLC Sensitivity Assays
Triton X-114 (TX114) phase separation experiments were performed accord-
ing to Bordier (1981) and as described previously (Heinz et al., 2012). PI-PLC
experiments were carried out by incubation of samples with 0.5 U/ml PI-PLC
(Invitrogen) for 30 min on ice. See the Supplemental Experimental Procedures
for further information.
Phosphodiesterase Enzymatic Activity
Generation of p-nitrophenol from bis-p-nitrophenolphosphate by phosphodi-
esterase activity was measured as absorbance at 405 nm in 96-well plates
with 100 ml reaction volume. Kinetic measurements were carried out using
325 ng/ml enzyme purified from Sf9 insect cells in HEPES buffer (20 mM
[pH 7.8]) with a substrate concentration as indicated. pH optima were deter-
mined by incubation of enzymes purified from Sf9 insect cells or HEK293T
cells in the presence of different buffers adjusted to the indicated pH in
the presence of 1 mM substrate. For determination of the impact of point
mutations, enzymes were incubated with HEPES buffer (20 mM [pH 7.8])
in the presence of 1 mM substrate. For measurement of cell-associated
enzymatic activity, cells were incubated in 96-well plates with isotonic
Tris-buffered saline (TBS) in the presence of 1 mM substrate at 37C and
5% CO2.
Membrane Fluidity Measurements
Membrane fluidity measurements were carried out using the fluorescent probe
di-4-ANEPPDHQ following a modified protocol from Owen et al. (2012). See
the Supplemental Experimental Procedures for additional information.
Lipidomics
1.5 3 107 RAW264.7 cells stably expressing SMPDL3B-specific or control
small hairpin RNA (shRNAs) were seeded in 10-cm dishes in serum-free
DMEM medium as five technical replicates and incubated for 2 hr at 37C,
5% CO2. Cells were harvested into ice-cold PBS and centrifuged for 5 min
at 300 3 g, 4C, and pellets were resuspended in 50 ml PBS, transferred to
Eppendorf tubes, and frozen in liquid nitrogen for further processing. Samples
were hydrated by adding 200 ml H2O and extracted by addition of 600 ml
methanol/chloroform (1:2 v/v) by vigorously vortexing the samples three times
for 1 min with 5-min intervals. After addition of 300 ml chloroform and 2 ml of
100 mM KCl samples were vortexed three times for 30 s with 1-min intervals.
Samples were centrifuged at 9,000 rpm for 2 min at 4C; the lower, organic
phase was transferred to new tubes and dried in a SpeedVac centrifuge.
Lipids were quantified by HPLC/MS as described previously with corre-
sponding internal standards including C17-Cer, C12-SM, C8-GluCer, C20-
LPC, and PC-14:0/14:0 (Avanti Polar Lipids) (Shui et al., 2011). Individual
lipids were normalized to phosphatidylcholine and sphingomyelin levels.
In Vivo Experimental Procedures
HeterozygousSmpdl3b+/mice (B6N;B6N-Smpdl3b < tm1a(EUCOMM)Wtsi >
/H) were purchased from the EMMA consortium (EUCOMM) and shipped from
the MRC. Smpdl3b homozygous knockout was confirmed by genotyping
using the following primers: SMPDL3B WT 50 -GTG TAA GCC TTC TCC
CCC AG-30; SMPDL3B WT 50-CAG AAA AAG TTC TAC GGA CCA GC-30;
SMPDL3B MUT 50-TTG GTG ATA TCG TGG TAT CGT T-50. Wild-type
C57BL/6J mice were obtained from Charles River Laboratories and bred at
the same location as Smpdl3-deficient mice. Pathogen-free 9- to 11-week-
old female C57BL/6J and homozygous B6N;B6N-Smpdl3btm1a(EUCOMM)Wtsi/
HSmpdl3b/mice were used in all in vivo experiments, which were approved
by the Animal Care and Use Committee of the Medical University of Vienna.
Mice were injected intraperitoneally with 50 mg LPS in 200 ml of saline per
mouse. After 6 hr, mice were sacrificed, peritoneal lavage was performed,
and blood was taken. Cell counts were determined on each peritoneal lavage
sample stained with Tuerks solution, and differential cell counts were per-
formed on cytospin samples stained with Giemsa. E. coli-dependent perito-
nitis was induced as described previously (Knapp et al., 2007). In brief,
E. coliO18:K1 was cultured in Luria-Bertani medium (Difco) at 37C, harvested
at mid-log phase, andwashed twice before inoculation. Mice were injected i.p.
with 1–23 104 cfu E. coli in 200 ml saline per mouse. The inoculum was plated
on blood agar plates to determine viable counts. Mice were sacrificed, and
blood was isolated after 6 hr.
Bioinformatic Analysis and General Statistics
Protein sequences and information were retrieved from UniProtKB database
(2012). Additional information on domain organization was obtained through
the NCBI conserved domain database (CDD) (Marchler-Bauer et al., 2011).
Protein homology searches were carried out using NCBI Blast (Altschul
et al., 1990). Expression data for murine SMPDL3B were extracted from the
BioGPS gene annotation portal (Lattin et al., 2008; Wu et al., 2009). p values
were calculated with two-tailed t tests, unless otherwise indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.05.006.
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